Form 4 for BCTX BriaCell Therapeutics Corp.
Accepted 2022-12-20 00:00:00 ET · period of report 2022-12-20 · accession 0001493152-22-036060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-20 | 2022-12-20 | BCTX | Bondarenko Jamieson | Dir | P - Purchase | $5.35 | +22.0K | 141.9K | +18% | +$117.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-20 | P | A | 22,000 | $5.35 | 141,856 | D | — | — |